Home
Photo of Mattias Ekstedt

Mattias Ekstedt

Deputy Head of Department, Senior Associate Professor

My research aims to improve the quality of life for patients through innovative treatments and diagnostic techniques. Through my teaching, I seek to spread knowledge about chronic liver diseases and convey what makes the medical profession exciting.

About me

CV

  • 2003 Medical Degree
  • 2008 Doctoral Degree
  • 2010-2015 LiÖ Research Assistant (Fo-Ass)
  • 2011 Specialist, Internal Medicine
  • 2013 STINT-Scholarship “Excellence in Teaching”, New York University, USA
  • 2013-2019 Medical Doctor (Specialistläkare), Gastroenterology and Hepatology
  • 2015-2021 Senior Lecturer (Kombinationsanställning), HMV
  • 2019- Main/Co-Supervisor for > 15 PhD students
  • 2019- Senior Consultant (Överläkare), Stomach and Intestine Department
  • 2020 Associate Professor (Docent), Gastroenterology and Hepatology
  • 2021- Senior Associate Professor, HMV

Teaching assignments

Medical Programme, LiU

  • Academic Group Supervisor
  • Course Manager K6
  • Member and former Chair, GNM Theme Group
  • Lecturer, Seminar Leader
  • Developed MEQ exams, OSCE, and oral/practical exams
  • Main Supervisor for Advanced Projects

Nursing Programme, LiU

  • Examiner, IMO3

Networks

  • Founder and Member, The Study Group for Ectopic Fat Storage
  • Member, SWEHEP
  • Board Member, Mag-Tarmfonden
  • Steering Committee Member SweLiv
  • Former National Lead for Sweden in LITMUS
  • Member, EASL International Liver Foundation NAFLD Policy Review Study Group
  • Center for Medical Image Science and Visualization, CMIV

Awards

News

Demonstration of MR elastography.

Fatty liver – but not liver damage – common in type 2 diabetes

Six out of ten people with type 2 diabetes had fatty liver in a new study. Of these, only a small percentage had developed more severe liver disease. Type 2 diabetes in combination with obesity is linked to a greater risk.
Mattias Ekstedt, Nils Dahlström, Peter Lundberg, Bengt Norén and Patrik Nasr.

Adverse muscle composition linked to risk in fatty liver disease

Obesity and a sedentary lifestyle contribute to an increasing number of people developing fatty liver disease. According to a new study, poor muscle health may be a marker of risk for developing sequelae.
Mattias Ekstedt, Nils Dahlström, Peter Lundberg, Bengt Norén and Patrik Nasr.

Liver examinations without needles

How is your liver doing? Decades of research into the use of magnet resonance imaging is now being put to work to gain information about patients’ livers – without needles.

Publications

Cover of publication ''
Mattias Ekstedt, Lennart E Franzén, Ulrik L Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar, Stergios Kechagias (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Hepatology , Vol.44 , s.865-873 Continue to DOI

Cover of publication ''
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz (2015)
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

Hepatology , Vol.61 , s.1547-1554 Continue to DOI

Cover of publication ''
Patrik Nasr, Simone Ignatova, Stergios Kechagias, Mattias Ekstedt (2018)
Natural history of nonalcoholic fatty liver disease: A prospective follow-up study with serial biopsies.

Hepatology communications , Vol.2 , s.199-210 Continue to DOI

2025

Ying Shang, Johan Vessby, Kamal Kant Mangla, Riku Ota, Marc Kunkel Winther, Mattias Ekstedt, Hannes Hagstrom (2025) Association between invasive and noninvasive liver disease assessments and long-term clinical outcomes in MASLD Scandinavian Journal of Gastroenterology (Article in journal) Continue to DOI
Wile Balkhed, Martin Bergram, Fredrik Iredahl, Markus Holmberg, Carl Edin, Carljohan Carlhäll, Tino Ebbers, Pontus Henriksson, Christian Simonsson, Karin Rådholm, Gunnar Cedersund, Mikael Forsgren, Olof Dahlqvist Leinhard, Cecilia Jönsson, Peter Lundberg, Stergios Kechagias, Nils Dahlström, Patrik Nasr, Mattias Ekstedt (2025) Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care Journal of Internal Medicine, Vol. 298, p. 173-187 (Article in journal) Continue to DOI
Julia Blomdahl, Mikael Aberg, Michael Friden, Hakan Ahlstrom, Paul Hockings, Johannes Hulthe, Niclas Eriksson, Katja Gabrysch, Patrik Nasr, Ulf Riserus, Stergios Kechagias, Fredrik Rorsman, Mattias Ekstedt, Johan Vessby (2025) Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study Scandinavian Journal of Gastroenterology (Article in journal) Continue to DOI
Cecilia Jönsson, Showgy Ma'ayeh, Boxi Zhang, Stergios Kechagias, Mathias Liljeblad, Patrik Nasr, Sara F. Hansson, Mattias Ekstedt (2025) Vascular endothelial growth factor A, a potential non-invasive biomarker for metabolic dysfunction-associated steatotic liver disease progression Clinical Biochemistry, Vol. 137, Article 110920 (Article in journal) Continue to DOI
Jonas Agholme, Kim Ahtola, Ebba Toll, Carljohan Carlhäll, Pontus Henriksson, Stergios Kechagias, Peter Lundberg, Patrik Nasr, Oleg Sysoev, Magnus Wijkman, Mattias Ekstedt, Martin Ulander, Fredrik Iredahl (2025) Clinically available predictors of obstructive sleep apnoea requiring treatment in type 2 diabetes patients in primary care Scientific Reports, Vol. 15, Article 8710 (Article in journal) Continue to DOI

Research

A X-ray image of a liver

DETECT-HCC-ESLD

A comparative study of MRI and ultrasound for detection of primary hepatocellular carcinoma, body composition and risk factors for decompensation in liver cirrhosis (DETECT-HCC-ESLD)
Photo of EPSONIP project meeting

EPSOMiP

The research project EPSOMIP brings together a multidisciplinary team of researchers with a shared interest in exploring the link between fatty liver, epicardial fat, and cardiovascular disease in type 2 diabetes.
View of a scanner room bathed in blue light

ACCESS

A rapid, non-invasive, Clinical surveillance for CachExia, Sarcopenia, portal hypertension and hepatocellular carcinoma in End-Stage Liver Disease
Bild på utsnitt av fettlever

Metabolic dysfunction-associated steatotic liver disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) previously known as non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which has become the most common liver disease affecting adults and children.
Five man are standing in front of a big screen showing MR images.

The study group of ectopic fat storage

Vi studerar hur fettinlagring i olika organ, så som lever, muskel och hjärta, ökar risken för sjukdomsutveckling. Förhoppningen är att kartläggning kommer att hjälpa oss att identifiera de individer som löper högst risk att utveckla sjukdom.
Campus US with cherry blossom in the foreground.

SciLifeLab Linköping

SciLifeLab Linköping is both a local and a national research infrastructure, with unique technologies and expert competence accessible for academic and industrial researcher in the field of life sciences, health and data-driven life science.

Earlier projects

LITMUS - Liver Investigation: Testing Marker Utility in Steatohepatitis (2017-2022) CORDIS keyword LITMUS

Coworkers

Photo of Patrik Nasr

Patrik Nasr

Adjunct Associate Professor, Docent

Placeholder for missing image of Stergios Kechagias

Stergios Kechagias

Professor

Photo of Mikael Forsgren

Mikael Forsgren

Adjunct Associate Professor

Photo of Olof Dahlqvist Leinhard

Olof Dahlqvist Leinhard

Associate Professor

Placeholder for missing image of Jennifer Linge

Jennifer Linge

Affilierad forskare

Photo of Gunnar Cedersund

Gunnar Cedersund

Associate Professor, Docent

Photo of Valentin Kindesjö

Valentin Kindesjö
Photo of Nils Dahlström

Nils Dahlström

Associate Professor, Head of Unit

Wolf Bartholomä

PhD student

Photo of Peter Lundberg

Peter Lundberg

Adjunct Professor

Photo of Johan Kihlberg

Johan Kihlberg

Affilierad forskare

Photo of Carl-Johan Carlhäll

Carl-Johan Carlhäll

Professor

Photo of Tino Ebbers

Tino Ebbers

Professor

Photo of Carl Fredholm

Carl Fredholm
Placeholder for missing image of Joakim Alfredsson

Joakim Alfredsson

Senior Associate Professor

Photo of Torsten Olbers

Torsten Olbers

Professor

Photo of Bijar Ghafouri

Bijar Ghafouri

Professor, Head of Unit

Photo of Cecilia Jönsson

Cecilia Jönsson

Principal Research Engineer

Photo of Christian Simonsson

Christian Simonsson
Photo of Martin Henriksson

Martin Henriksson

Senior Associate Professor

Photo of Fredrik Iredahl

Fredrik Iredahl

Senior Associate Professor

Photo of Martin Bergram

Martin Bergram
Photo of Karin Rådholm

Karin Rådholm

Senior Associate Professor

Photo of Wile Balkhed

Wile Balkhed
Photo of Markus Holmberg

Markus Holmberg
Placeholder for missing image of Byron Lykiardopoulos

Byron Lykiardopoulos
Placeholder for missing image of Jonas Agholme

Jonas Agholme

Bengt Norén

MD, Region Östergötland

Simone Ignatova

Kim Ahtola

Organisation

Illustration of the letters HMV

Department of Health, Medicine and Caring Sciences (HMV)

The research areas at HMV include experimental basic research to clinical, social and public health research. We conduct high-quality education in the sought-after care professions.
Close up of three doctors dressed in surgical clothes. One stands with his back to the camera.

Division of Diagnostics and Specialist Medicine (DISP)

The division consists of three units (internal medicine, cardiovascular and radiological sciences) and contains seven subject areas within which research and teaching are conducted.
Five people in a laboratory.

Faculty of Medicine and Health Sciences (MEDFAK)

The Faculty of Medicine and Health Sciences conducts research and education within medicine, healthcare and public health.

Tags